Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group - Wikidata - wikimedia - TriplyDB

Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group

Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group

http://www.wikidata.org/entity/Q35046171

about

The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) - Mechanisms and Opportunities Molecular Genetic Markers in Acute Myeloid Leukemia Mechanisms of epigenetic regulation of leukemia onset and progression Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AML Chemotherapy-induced hypomethylation of N-myc downstream-regulated gene 4 in the bone marrow of patients with acute myeloid leukemia.Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.DNMT3A in haematological malignancies.Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia.Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report.Cancer stem cells: impact, heterogeneity, and uncertainty Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group.Prognostic significance of IDH1 mutations in acute myeloid leukemia: a meta-analysis Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification.Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse Gene expression profiling of the DNMT3A R882 mutation in acute leukemia.High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group.Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to Flt3-ITD mutations.Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia Novel therapies for children with acute myeloid leukaemia.Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.Isocitrate dehydrogenase mutations in leukemia.Acute myeloid leukemia with DNMT3A mutations.Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design.Understanding chronic neutropenia: life is short.Effects of bufalin on up-regulating methylation of Wilm's tumor 1 gene in human erythroid leukemic cells.Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.DNMT3A in Leukemia.Molecular landscape in acute myeloid leukemia: where do we stand in 2016 Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.DNMT3A mutations in Chinese childhood acute myeloid leukemia.DNMT3A mutations are rare in childhood acute myeloid leukemia.DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian study.Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers.The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia.Lentivirus-mediated RNA interference targeting FAMLF-1 inhibits cell growth and enhances cell differentiation of acute myeloid leukemia partially differentiated cells via inhibition of AKT and c-MYC.Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia.

P2860

Q26744506-7056DEE0-23A8-4813-B5D5-70A9DEF046E5 Q26799606-3250A376-01AF-4C30-8F75-CB34730F6CDC Q26861785-82E557BF-5AB5-4D36-9AEE-C39592EA4858 Q33702150-CAB3058B-6449-4995-AD26-F890490FB4C3 Q33707331-CA70A563-681F-4A13-A8A9-F68015DF21A5 Q34069626-BA4C2C7D-8621-49BF-B2F4-5F4269C6B92D Q34463554-FEB4D6CD-3DB2-42E2-8D31-87106B561542 Q34632784-61A539A0-42FC-4BCA-A2DA-398C7563116B Q34635511-E50FC854-8B79-4026-AD00-1E81DCB31818 Q35265916-32AE6479-DD5B-4BA5-885F-FDBBEADFF293 Q35687895-2114AFB6-333E-49E6-9E85-37E7372512A9 Q35857599-99E5E71D-0377-4768-A180-6F4C99400033 Q36303319-0A10CFA4-8682-4F37-8BC8-93B789EBAD7F Q36439908-1921B6DE-36EB-491D-9C1B-9F87A7F70AF5 Q36589155-06C6E275-AF71-4E43-9785-7E54960F15CD Q36849666-2FB56F38-F0A5-42F7-953D-0B40FB3ABB02 Q36917869-EED9F253-1A38-49B3-B575-B5EA3E7DECCF Q37092716-E143D17A-55AC-4295-AE71-903D53B9E9FF Q37125803-9B8ABDD2-B422-4D55-89EF-00604443A29C Q37496355-12A7BA56-DB6E-44BB-A3AD-81B172733011 Q38068816-9E0856ED-5AB5-4403-BA48-8ABB31033056 Q38096798-00455A40-4F72-4756-83B8-0BEB438CBF63 Q38097334-7B69143D-858E-47C7-B603-10DD25AE26BE Q38133721-732730F7-E235-40CD-AA96-117BD6AE200D Q38166821-21BD30C2-9947-4EBE-A9D8-956AD554A159 Q38253011-44FF7C6D-72DF-44BA-A91E-50920E26769F Q38604646-D418623E-F8C4-4318-B482-79917536CC91 Q38709450-E93084E3-6C5F-4316-8CF9-C2275C0AFB8F Q38836107-889E60B2-A486-454D-842B-73547E8AF9AB Q39047646-59B27F3D-EF2A-4E77-B8C2-74318520E275 Q39116878-FD976EDE-FE44-41F6-A4F5-6F0B2F63BF64 Q40513597-EC7F9D28-A8B8-4970-B941-001034A07B46 Q42242884-E7BD7AA8-822F-45BF-88C4-533BD7B1CD09 Q42852417-67D4126E-844D-4BCA-BAC4-CA6BA86CF39B Q43004456-36EC1D26-BA43-49C3-A3F8-7EBC9C1E0A3B Q44022767-6D6564C8-86EC-4504-BB97-6936EB663D34 Q46135008-047C1478-B055-4B84-947C-AB5EC06D7BD9 Q46802244-768702B5-F813-4B74-86DE-77B9BB183B2B Q47117677-0E1853E3-1333-417E-93D4-E632F827A3B7 Q47136441-DD95FF7D-F98A-4A0B-93BA-D4B0058EE6C1

P2860

Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group

http://www.wikidata.org/entity/Q35046171

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Leukemic mutations in the meth ...... the Children's Oncology Group

@en

type

label

Leukemic mutations in the meth ...... the Children's Oncology Group

@en

prefLabel

Leukemic mutations in the meth ...... the Children's Oncology Group

@en

P1433

Q35046171-DA2FBF3C-55A4-4AE1-BA89-FDA3190C9F5C

P1476

Q35046171-42953A73-BF92-4823-9066-B17BE378D18B

P2093

Q35046171-33800EE5-A261-4E0F-8270-87605A829591

Q35046171-71170362-BA7F-42DB-AF25-3A42C2472912

Q35046171-77D5E978-7593-4771-B2C9-B7F4FF518A4B

Q35046171-8143A629-0045-4EDB-89C0-DC3440992DEE

Q35046171-C45AF63D-9CB5-431B-8BF9-0095954F3E54

Q35046171-E745D1A9-065E-4D6C-8C9C-1267655BBFED

P2860

Q35046171-05E1162A-06C7-47A5-9C0F-34C6AAD82DF9

Q35046171-204D9D8B-DAB8-4903-BFEE-67C2FACC95E9

Q35046171-285A95B7-7288-4640-82CA-40F6A9B746BF

Q35046171-2BC211B4-881A-4BE9-9092-E165DC08A1DF

Q35046171-3FB47717-A1BA-47CF-B4C5-9DD878B377EB

Q35046171-415A6FDC-B3B4-4ABB-BA53-AFCCBE7FB08D

Q35046171-41801F37-4696-4259-A2DD-BF30493C0AEA

Q35046171-484F8645-5E55-4221-916C-F86A332799C6

Q35046171-49846422-DDEC-4957-AA50-EBDE81D07145

Q35046171-4C11CE7C-2D60-470A-B514-4787C7289C35

P304

Q35046171-3089CE64-AA14-4432-ABDF-D24DB9F82B9A

P31

Q35046171-4B869B05-949C-4867-BF72-DF9C3ADEF681

P356

Q35046171-A0853886-D6F1-4581-8B31-72D7559C2703

P433

Q35046171-1A3FDF2B-DAEC-4F06-941A-5D5B98992E9E

P478

Q35046171-E06C996C-48A2-4FD4-AB9B-CCB9C0AAA6A9

P50

Q35046171-28428AE7-DFF1-4A60-9250-79B044BFE868

Q35046171-85459B8D-864A-458E-A2CB-E98BB97DF8EC

P577

Q35046171-5D98C0F6-8969-4513-AA38-386647D54484

P5875

Q35046171-E2065372-3E64-4E50-902A-D29E1EAFCB04

P698

Q35046171-6C519336-C17F-46AC-BE5B-01C8FAFB3F62

P921

Q35046171-89268AEA-F1FF-4AF5-9C8E-17EEBA0560CE

P932

Q35046171-6C211403-267D-447A-B462-3FB24C643471

P356

P1433

Pediatric Blood & Cancer

P1476

Leukemic mutations in the meth ...... the Children's Oncology Group

@en

P2093

Alan S Gamis

http://www.w3.org/2001/XMLSchema#string

Jason Joaquin

http://www.w3.org/2001/XMLSchema#string

Robert B Gerbing

http://www.w3.org/2001/XMLSchema#string

Soheil Meshinchi

http://www.w3.org/2001/XMLSchema#string

Susana C Raimondi

http://www.w3.org/2001/XMLSchema#string

Todd A Alonzo

http://www.w3.org/2001/XMLSchema#string

P2860

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

Structural and functional alterations of FLT3 in acute myeloid leukemia

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

DNMT3A Mutations in Acute Myeloid Leukemia

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.

Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia

Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification

Epigenetics in cancer

P304

204-209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.23179

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Matthew A Kutny

P577

2011-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51061734

http://www.w3.org/2001/XMLSchema#string

P698

21504050

http://www.w3.org/2001/XMLSchema#string

P921

P932

3115394

http://www.w3.org/2001/XMLSchema#string